PAM
RPRX icon

Panagora Asset Management’s Royalty Pharma RPRX Stock Holding History

Panagora Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
+240,184
New +$12.5M 0.04% 305
2025
Q2 		– Sell
-49,438
Closed -$1.54M – 1202
2025
Q1 		$1.54M Sell
49,438
-14,226
-22% -$451K 0.01% 578
2024
Q4 		$1.62M Buy
63,664
+544
+0.9% +$14.4K 0.01% 560
2024
Q3 		$1.79M Hold
63,120
– – 0.01% 556
2024
Q2 		$1.66M Sell
63,120
-129,378
-67% -$3.59M 0.01% 569
2024
Q1 		$5.85M Sell
192,498
-88,517
-31% -$2.61M 0.03% 309
2023
Q4 		$7.89M Buy
281,015
+215,142
+327% +$5.91M 0.04% 255
2023
Q3 		$1.79M Buy
65,873
+16,525
+33% +$491K 0.01% 561
2023
Q2 		$1.52M Hold
49,348
– – 0.01% 645
2023
Q1 		$1.78M Buy
49,348
+17,778
+56% +$659K 0.01% 616
2022
Q4 		$1.25M Sell
31,570
-19,088
-38% -$797K 0.01% 801
2022
Q3 		$2.04M Sell
50,658
-66,325
-57% -$2.83M 0.01% 593
2022
Q2 		$4.92M Buy
116,983
+105,620
+930% +$4.33M 0.03% 385
2022
Q1 		$443K Hold
11,363
– – ﹤0.01% 1251
2021
Q4 		$453K Hold
11,363
– – ﹤0.01% 1255
2021
Q3 		$411K Sell
11,363
-2,498
-18% -$97.1K ﹤0.01% 1390
2021
Q2 		$568K Sell
13,861
-1,647
-11% -$70.1K ﹤0.01% 1277
2021
Q1 		$676K Buy
15,508
+8,349
+117% +$396K ﹤0.01% 1187
2020
Q4 		$358K Buy
+7,159
New +$304K ﹤0.01% 1354

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's RPRX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 240,184 shares worth $13.5M. The stake represents 0.04% of the portfolio and ranks #305 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in RPRX as recently as Q1 2025.

Panagora Asset Management first reported a position in RPRX in Q4 2020 and has held it in 19 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Panagora Asset Management held 240,184 shares of Royalty Pharma worth $13.5M as of Q2 2026.
  • Royalty Pharma was a new Panagora Asset Management position in Q2 2026.
  • Royalty Pharma made up 0.04% of Panagora Asset Management's portfolio in Q2 2026, its #305 holding.
  • Panagora Asset Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 19 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.